000 01194 a2200301 4500
005 20250518073326.0
264 0 _c20200805
008 202008s 0 0 eng d
022 _a1520-4383
024 7 _a10.1182/hematology.2019000048
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGerds, Aaron T
245 0 0 _aBeyond JAK-STAT: novel therapeutic targets in Ph-negative MPN.
_h[electronic resource]
260 _bHematology. American Society of Hematology. Education Program
_c12 2019
300 _a407-414 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAged
650 0 4 _aHumans
650 0 4 _aJanus Kinases
_xgenetics
650 0 4 _aMale
650 0 4 _aPolycythemia Vera
_xdrug therapy
650 0 4 _aPrimary Myelofibrosis
_xdrug therapy
650 0 4 _aSTAT Transcription Factors
_xgenetics
650 0 4 _aSignal Transduction
650 0 4 _aThrombocythemia, Essential
_xdrug therapy
773 0 _tHematology. American Society of Hematology. Education Program
_gvol. 2019
_gno. 1
_gp. 407-414
856 4 0 _uhttps://doi.org/10.1182/hematology.2019000048
_zAvailable from publisher's website
999 _c30392865
_d30392865